A systematic review of 25 studies found physical activity significantly reduces heart disease risk by 40%, with moderate-intensity exercise lowering systolic blood pressure by up to 15mmHg. Replacing sedentary behaviors with daily activities can also lower all-cause mortality.
The American College of Cardiology emphasizes that combating obesity in the US will require individual and societal changes to reduce cardiovascular risks. Implementing policy-level interventions, increasing physical activity, and promoting healthier diets are key aspects of this approach.
A review paper published in the Journal of the American College of Cardiology found that high levels of optimism can lead to a reduced risk of heart disease. Optimistic patients were more likely to engage in healthy behaviors such as regular physical activity, healthy eating and not smoking.
A Swiss study published in the Journal of the American College of Cardiology found that children born through IVF may have a higher risk of developing arterial hypertension by age 16. The study measured ambulatory blood pressure and found that ART adolescents had a higher systolic and diastolic blood pressure than control participants.
The prevalence of hypertension globally is high and continues to increase. Targeted and population-based strategies can lead to better prevention and control of hypertension.
The American College of Cardiology recommends incorporating smoking cessation into cardiovascular care, with a focus on evidence-based treatments. Community and policy-level interventions, such as smoke-free laws and education campaigns, also play a crucial role in reducing tobacco-related heart disease risk.
The American College of Cardiology and the American Heart Association released an updated guideline for managing adult congenital heart disease (ACHD) patients, incorporating new data and growing expertise. The guideline presents a new classification system that captures complexity in both anatomy and physiology.
Research suggests that policy strategies such as nutrition labeling, taxing sugar sweetened beverages, and promoting healthy environments can improve diets. The American College of Cardiology recommends these policies to address the complex dietary risk factor modification needed to reduce cardiovascular disease prevalence.
A recent study found that 8.3% of trastuzumab-treated patients developed heart failure, highlighting the need for cardiac monitoring in high-risk breast cancer patients. The study also showed a consistent increase in heart failure risk with age, emphasizing the importance of prioritizing cardiac monitoring for younger patients.
Legumes have been shown to successfully reduce coronary heart disease and improve blood glucose levels. Additionally, moderate coffee consumption is associated with lower risks of all-cause and cardiovascular mortality. A predominantly plant-based diet with limited animal products appears to be beneficial for heart health.
The study found a 16.1% decline in ICD placements not meeting Medicare coverage criteria at hospitals that settled with the DOJ, while non-Medicare patients also showed declines. Hospital-level variation remained, with top performers having less than 3.8% of ICDs not meeting criteria
Review papers explore how technology will change cardiovascular care, with artificial intelligence enhancing personalized medicine and digital health accelerating clinical research. Mobile health advances track physical activity and fitness, promoting heart-healthy habits.
Research reveals that homeless individuals are at a high risk of developing cardiovascular disease due to lack of access to healthcare and long-term management. This population faces unique challenges such as untreated hypertension and diabetes, smoking addiction, and chronic mental illness.
A higher testosterone to estradiol ratio is associated with an elevated risk of cardiovascular disease, coronary heart disease, and heart failure. Higher total testosterone levels are linked to an increased risk of coronary heart disease and total cardiovascular disease.
Current research does not support the use of vitamin or mineral supplements in preventing or treating heart disease. However, naturally derived nutrients from plant-based foods can help cut heart disease risk. Folic acid supplements have shown a reduction in stroke risk.
A study found that hypertensive adults with low platelet count and high homocysteine levels reduced their risk of first stroke by 73% with folic acid supplements. The treatment was particularly effective for patients at high risk, suggesting a potential cost-effective primary prevention strategy.
A study by the American College of Cardiology found that women are underrepresented in cardiovascular trials, with proportions ranging from 22-81% compared to disease populations. Researchers emphasize the need for better representation to determine potential gender differences in treatment responses.
A recent study found that women are consistently less intensively treated with high-intensity statins after a heart attack, even when prescribed, and across various patient characteristics. This underutilization can lead to preventable vascular events, emphasizing the need for clinicians to communicate the benefits of these medications.
Research presented at the American College of Cardiology's 67th Annual Scientific Session found that canakinumab had no effect on rates of newly diagnosed diabetes in people with prediabetes. Despite cardiovascular benefits, the drug did not slow or prevent the progression from prediabetes to diabetes.
Patients with critical limb ischemia treated with JVS-100 did not experience faster wound healing compared to those receiving a placebo, despite being in a highly monitored environment. The study's findings highlight the need for additional therapies to aid patients' recovery.
A study presented at the American College of Cardiology's Annual Scientific Session found that African-American men who received frequent monitoring and medication management from a specially-trained pharmacist in their barbershop saw a marked drop in blood pressure, with systolic blood pressure dropping by an average of 21 mm Hg. The ...
Patients treated with beta blocker metoprolol for 30 days before and after noncardiac surgery were less likely to have heart attacks, but more likely to die or have strokes one year later. The study found that the benefits of beta blockers in reducing heart attacks did not outweigh the increased risk of death or stroke.
A study found that patients with a high-risk PFO who received a medical device to close the hole in their heart after a stroke fared better than those who received medications alone. The trial suggested that closure can help prevent subsequent strokes and related problems, particularly in those with a high-risk PFO.
The experimental drug andexanet has been shown to control serious bleeding in patients taking Factor Xa inhibitors. The study found that andexanet rapidly reversed the anticoagulant effect of these drugs without significant safety problems, achieving clinical hemostasis in 83% of patients.
A recent study found that six-month dual antiplatelet therapy increases the risk of heart attacks in patients with acute coronary syndrome (ACS). The SMART-DATE trial showed that short-term treatment is not safe for ACS patients who have received drug-eluting stents, highlighting the need for prolonged DAPT in these cases.
The CARES trial found that long-term febuxostat use in patients with heart disease significantly increases the risk of death, despite not raising cardiovascular outcomes. Researchers were unable to identify a biological mechanism explaining this finding.
A new combination pill of three low-dose medications has been shown to significantly increase the number of patients reaching blood pressure targets compared to usual care. The 'Triple Pill' resulted in a 70% control rate at six months, with benefits seen straight away and maintained until six months.
A study found that reducing co-payments for patients with heart attack medication improved both patient and physician adherence to recommended treatment. The study also found no significant differences in rates of death, heart attack, or stroke between groups.
A study found that women with breast cancer who took the beta blocker carvedilol during chemotherapy had lower levels of a protein indicative of heart injury, but no difference in heart function. The study's lead author notes that further research is needed to confirm these findings and explore potential benefits for higher-risk patients.
A study found that ACE-inhibitors and beta blockers can reduce the risk of heart damage in women receiving anthracycline-based chemotherapy alongside trastuzumab. However, these medications were not effective for those without a history of anthracycline exposure.
A new inhaled medication for heart failure with preserved ejection fraction failed to improve exercise capacity, daily activity levels, or quality of life. The study's findings suggest that adherence issues and short treatment duration may have contributed to the treatment's ineffectiveness.
Patients treated with dabigatran had a 28% lower risk of major cardiovascular complications compared to those receiving a placebo. Dabigatran also showed significant benefits in reducing the risk of specific events such as heart attack, stroke and blood clots.
Patients with advanced heart failure who received a novel heart pump experienced no malfunctions requiring replacement, and their risk of stroke was halved compared to those who received the established version. The new device uses fully magnetic levitation technology to push blood through the device and into the aorta.
A new study found that using genetic information to inform drug choice reduced adverse events by 42 percent in patients with acute coronary syndrome. Genetic testing led to different prescribing patterns, including more frequent use of prasugrel and ticagrelor.
In a trial of over 3,800 patients treated for STEMI at more than 180 centers, researchers found that ticagrelor is safe to use in combination with clot busters in patients younger than 75. The study met its primary endpoint indicating no difference in major bleeding rates between ticagrelor and clopidogrel.
A large trial found that statins significantly reduced major adverse cardiac events among patients undergoing PCI, but not in the broader population. Patients who received a loading dose of statin before PCI were 28% less likely to experience a major adverse cardiac event and 32% less likely to have a heart attack.
The wearable cardioverter defibrillator was associated with a 35% lower risk of death in patients recovering from a heart attack. While it didn't reduce sudden cardiac deaths, the device showed promise as an interim therapy for patients awaiting evaluation for implantable cardioverter defibrillators.
A study found that wearing a self-adhering chest patch can detect atrial fibrillation (AFib) more quickly than usual care, with participants experiencing nearly three times the likelihood of being diagnosed. The patch recorded continuous ECG data over 14 days, capturing electrical activity and identifying rhythm abnormalities, includin...
The study found that alirocumab reduced rates of major adverse cardiovascular events by 15% compared to placebo, with a greater effect in patients with highest LDL cholesterol levels. The drug also showed significant safety and tolerability profiles.
A technology-based process significantly increased cardiac rehab referrals, reducing cardiovascular deaths and readmissions. The program provides resources for staff and patients, improving quality of life.
The NCDR Annual Conference brings together registry professionals to share best practices and learn from leading experts. Attendees will receive updates on new registries, strategies for improving patient care, and how to use registry data for decision-making purposes.
A study analyzing medical records from over 17.5 million patients found that people with inflammatory bowel disease are at elevated risk for a heart attack, regardless of traditional risk factors. Younger patients, especially those under 40 years old and females, face the highest risks.
A study found that large day-to-day swings in outdoor temperature are associated with a significantly increased risk of heart attacks. The researchers calculated the temperature fluctuation preceding each heart attack and found that a five-degree jump in temperature differential was linked to a 5% increase in heart attack rates.
A study by the American College of Cardiology found that listening to music during a standard cardiac stress test can prolong activity and participation. On average, participants who listened to music exercised for almost one minute longer than those without music.
A positive outlook may help improve outcomes for people with chronic angina, reducing hospital visits and revascularization procedures. Patients who were more optimistic had fewer episodes of heart-related hospital stays, even after accounting for overall health.
Walking for at least 40 minutes, two to three times a week, significantly lowers the risk of heart failure among post-menopausal women. The study found that brisk walks and walking frequency/duration/pace all contribute equally to this benefit, making walking an accessible form of exercise for older women.
A study by the American College of Cardiology found a strong correlation between geographic and seasonal trends in coronary heart disease hospitalizations and internet search queries. The research suggests that search data can be a useful resource for tracking heart disease over time and in different regions.
Researchers found that patients with a history of breast cancer or lymphoma are three times more likely to develop heart failure than those without cancer. Elevated risks were associated with diabetes, high doses of chemotherapy, and anthracycline drugs.
A new study presents a machine learning algorithm that accurately predicts heart attack diagnoses with a 94% accuracy rate, outperforming standard clinical models. The algorithm uses large collections of patient data to identify patterns and improve routine processes in healthcare delivery.
Women who breastfed for six months or more during pregnancy had higher levels of HDL cholesterol, lower triglycerides, and healthier carotid artery thickness compared to those who never breastfed. This suggests breastfeeding may reduce the risk of heart disease in women with normal blood pressure during pregnancy.